Children's Hospital Boston
Targeting Cell Pathway May Prevent Relapse of Leukemia
Published in Blood Weekly, April 8th, 2010
About 40 percent of children and up to 70 percent of adults in remission from acute myelogenous leukemia (AML) will have a relapse. In recent years, doctors have come to believe that this is due to leukemia stem cells, endlessly replicating cancer cells that generate the immature blood cells characteristic of leukemia and are resistant to typical cancer treatments. Now, researchers at Children's Hospital Boston have found a possible way to kill off these cells, and prevent them from initiating a relapse.
The study, published online March 26 in the journal Science, shows that leukemia stem cells cannot thrive without a particular cell pathway, known as the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-04-08)
More Articles from Blood Weekly
- NIH/National Institute on Aging
NIA researchers find gene to explain mouse embryonic stem cell immortality - Wiley-Blackwell
New therapies increase survival rates in post-transplant liver cancer patients - Acute Respiratory Distress Syndrome
Researchers from Natl Cheng Kung University Hospital publish findings in acute respiratory distress syndrome - BioSante Pharmaceuticals, Inc.
BioSante Announces Additional Positive Leukemia Vaccine Results and Second FDA Orphan Drug Designation - Breast Cancer
Studies from University of Verona add new findings in the area of breast cancer - Celera Corporation
Celera Publishes Data Extending the Association Between the KIF6 Gene Variant and Differential Reduction of Coronary Events From Statin Therapy to the Elderly With Prior Vascular Disease - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
